Leaflet GLIBENCLAMIDA ARENA 1.75mg tablets

Product code:
W41858004
Quantity:
1000
Indicated for:
type 2 diabetes mellitus
Route of administration:
oral
Substance:
glibenclamide (sulfonylurea antidiabetic)
ATC
A10BB01 — Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Precautions:

Hypoglycemia

Hypoglycemia

This medicine may lower blood sugar.

Glibenclamide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glibenclamide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, weight gain, dizziness, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLIBENCLAMIDA ARENA 1.75mg

Substance:
glibenclamide
Date of latest medicines list:
01-06-2026
Product code:
W41858004
Concentration:
1.75mg
Pharmaceutical form:
tablets
Quantity:
1000
Product type:
Generic medicine
Price:
133.08 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
ARENA GROUP S.A. - ROMANIA
Holder:
ARENA GROUP S.A. - ROMANIA
Number:
12120/2019/02
Shelf life:
3 years

Concentrations available for glibenclamide

  • 1.75mg
  • 3.5mg
  • 5mg

Compensation lists for GLIBENCLAMIDA ARENA 1.75mg Arena

NHP 5 (C2) - Diabetes

Price
133.08 RON
Copayment
104.00 RON
Patient
29.08 RON